# Cluster3-25 Analysis

## Proteins: 

CNNM1, CNST, CSRNP1, DSN1, DUSP16, KNL1, MAPKAPK3, MAPKAPK5, NELFA, NELFB, NELFCD, NELFE, NUF2, PMF1-BGLAP, PPP1R10, PPP1R2, RPS6KA4, RPS6KA5, TRIM28, ZFYVE16, ZNF274, ZNF8

Title: Nucleoplasmic Protein Complex Involved in Transcription Regulation and MAPK Signaling

Summary:

The human protein system analyzed consists of 21 proteins, with a majority involved in protein binding (21 proteins) and localized in the nucleus (14 proteins) and nucleoplasm (14 proteins). The system appears to be involved in transcription regulation, particularly by RNA polymerase II, and mitogen-activated protein kinase (MAPK) signaling. The presence of NELF complex proteins (NELFCD, NELFA, NELFB, NELFE) suggests a role in negative regulation of transcription elongation by RNA polymerase II. Additionally, several proteins exhibit protein serine/threonine kinase activity (MAPKAPK3, MAPKAPK5, RPS6KA4, RPS6KA5), indicating involvement in MAPK signaling pathways. Based on the cellular location and function, the system can be named the "Nucleoplasmic Protein Complex Involved in Transcription Regulation and MAPK Signaling."

References:

1. Narita, T., Yung, T. M., Yamamoto, J., Tsuboi, Y., Tanabe, H., Tanaka, K., ... & Yamaguchi, Y. (2007). NELF interacts with CBC and participates in 3' end processing of replication-dependent histone mRNAs. Molecular cell, 26(3), 349-365. [DOI: 10.1016/j.molcel.2007.04.011](https://doi.org/10.1016/j.molcel.2007.04.011)

2. Roux, P. P., & Blenis, J. (2004). ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiology and molecular biology reviews, 68(2), 320-344. [DOI: 10.1128/MMBR.68.2.320-344.2004](https://doi.org/10.1128/MMBR.68.2.320-344.2004)

3. Chevrier, N., Mertins, P., Artyomov, M. N., Shalek, A. K., Iannacone, M., Ciaccio, M. F., ... & Carr, S. A. (2011). Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell, 147(4), 853-867. [DOI: 10.1016/j.cell.2011.10.022](https://doi.org/10.1016/j.cell.2011.10.022)

4. Gillette, T. G., & Hill, J. A. (2015). Readers, writers, and erasers: chromatin as the whiteboard of heart disease. Circulation research, 116(7), 1245-1253. [DOI: 10.1161/CIRCRESAHA.116.305838](https://doi.org/10.1161/CIRCRESAHA.116.305838)

## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 21 | CNST, NELFCD, CNNM1, DSN1, MAPKAPK3, CSRNP1, KNL1, NUF2, PPP1R10, PPP1R2, ZFYVE16, NELFA, NELFB, NELFE, TRIM28, ZNF274, ZNF8, DUSP16, MAPKAPK5, RPS6KA4, RPS6KA5 |
| nucleus | 14 | NELFCD, MAPKAPK3, CSRNP1, KNL1, PPP1R10, NELFA, NELFB, NELFE, TRIM28, ZNF8, DUSP16, MAPKAPK5, RPS6KA4, RPS6KA5 |
| nucleoplasm | 14 | NELFCD, DSN1, MAPKAPK3, KNL1, NUF2, PPP1R10, NELFA, NELFB, NELFE, TRIM28, DUSP16, MAPKAPK5, RPS6KA4, RPS6KA5 |
| cytosol | 9 | DSN1, MAPKAPK3, KNL1, NUF2, ZFYVE16, NELFA, DUSP16, MAPKAPK5, RPS6KA4 |
| cytoplasm | 7 | MAPKAPK3, NELFB, ZNF274, DUSP16, MAPKAPK5, RPS6KA4, RPS6KA5 |
|  transcription by RNA polymerase II | 6 | CSRNP1, NELFA, NELFE, ZNF274, RPS6KA4, RPS6KA5 |
| RNA binding | 5 | NELFCD, PPP1R10, NELFB, NELFE, TRIM28 |
| nuclear body | 5 | DSN1, KNL1, PPP1R10, NELFA, NELFE |
| negative regulation of transcription elongation by RNA polymerase II | 4 | NELFCD, NELFA, NELFB, NELFE |
| NELF complex | 4 | NELFCD, NELFA, NELFB, NELFE |
| protein serine/threonine kinase activity | 4 | MAPKAPK3, MAPKAPK5, RPS6KA4, RPS6KA5 |
| ATP binding | 4 | MAPKAPK3, MAPKAPK5, RPS6KA4, RPS6KA5 |
| protein serine kinase activity | 4 | MAPKAPK3, MAPKAPK5, RPS6KA4, RPS6KA5 |
| chromatin binding | 4 | NELFA, NELFE, TRIM28, ZNF274 |
| negative regulation of transcription by RNA polymerase II | 4 | NELFE, TRIM28, ZNF274, ZNF8 |
|  DNA-templated transcription | 4 | TRIM28, ZNF274, RPS6KA4, RPS6KA5 |
| plasma membrane | 3 | CNST, CNNM1, NELFE |
| membrane | 3 | CNST, NELFCD, NUF2 |
| protein-containing complex | 3 | CNST, TRIM28, MAPKAPK5 |
| cell division | 3 | DSN1, KNL1, NUF2 |
| kinetochore | 3 | DSN1, KNL1, NUF2 |
| mitogen-activated protein kinase binding | 3 | MAPKAPK3, DUSP16, MAPKAPK5 |
| signal transduction | 3 | MAPKAPK3, ZFYVE16, MAPKAPK5 |
| intracellular signal transduction | 3 | MAPKAPK3, RPS6KA4, RPS6KA5 |
| protein autophosphorylation | 3 | MAPKAPK3, TRIM28, MAPKAPK5 |
| chromatin | 3 | CSRNP1, PPP1R10, NELFE |
| DNA binding | 3 | PPP1R10, TRIM28, ZNF8 |
| metal ion binding | 3 | PPP1R10, ZFYVE16, ZNF274 |
| chromatin remodeling | 3 | ZNF274, RPS6KA4, RPS6KA5 |
| intracellular membrane-bounded organelle | 2 | CNST, ZFYVE16 |
| nucleolus | 2 | DSN1, ZNF274 |
| calmodulin-dependent protein kinase activity | 2 | MAPKAPK3, MAPKAPK5 |
| MAP kinase kinase activity | 2 | MAPKAPK3, MAPKAPK5 |
| calmodulin binding | 2 | MAPKAPK3, MAPKAPK5 |
| calcium-dependent protein serine/threonine kinase activity | 2 | MAPKAPK3, MAPKAPK5 |
| MAPK cascade | 2 | MAPKAPK3, MAPKAPK5 |
| peptidyl-serine phosphorylation | 2 | MAPKAPK3, MAPKAPK5 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 2 | CSRNP1, ZNF274 |
| molecular_function | 2 | CSRNP1, NUF2 |
| sequence-specific DNA binding | 2 | CSRNP1, ZNF274 |
| attachment of spindle microtubules to kinetochore | 2 | KNL1, NUF2 |
| protein phosphatase inhibitor activity | 2 | PPP1R10, PPP1R2 |
|  histone H3-K4 methylation | 2 | NELFA, NELFE |
| zinc ion binding | 2 | TRIM28, ZNF8 |
| negative regulation of DNA-templated transcription | 2 | TRIM28, RPS6KA5 |
| RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2 | ZNF274, ZNF8 |
| magnesium ion binding | 2 | RPS6KA4, RPS6KA5 |
| histone H3S10 kinase activity | 2 | RPS6KA4, RPS6KA5 |
| histone H3S28 kinase activity | 2 | RPS6KA4, RPS6KA5 |
| negative regulation of cytokine production | 2 | RPS6KA4, RPS6KA5 |
| protein phosphorylation | 2 | RPS6KA4, RPS6KA5 |
| inflammatory response | 2 | RPS6KA4, RPS6KA5 |
|  CREB transcription factor activity | 2 | RPS6KA4, RPS6KA5 |
| post-translational protein modification | 2 | RPS6KA4, RPS6KA5 |
|  NF-kappaB transcription factor activity | 2 | RPS6KA4, RPS6KA5 |
| interleukin-1-mediated signaling pathway | 2 | RPS6KA4, RPS6KA5 |

